The firm is developing a shoebox-size gas chromatography instrument that could be used for routine screenings and critical illness detection and monitoring.
The firm will use biomarkers licensed from the University of Michigan to develop and commercialize an assay for identifying disease and monitoring treatments.
/PRNewswire/ Blu Biotech Inc. has formed a collaboration with University of Michigan (U-M) and its Max Harry Weil Institute for Critical Care Research and.
Blu Biotech Inc Announces a Patent License Agreement with University of Michigan streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.